Lingham Gareth, Yazar Seyhan, Lucas Robyn M, Walsh John P, Zhu Kun, Hunter Michael, Lim Ee Mun, Cooke Brian R, Mackey David A
Lions Eye Institute, Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Australia.
National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, Australia.
Transl Vis Sci Technol. 2019 Jan 22;8(1):13. doi: 10.1167/tvst.8.1.13. eCollection 2019 Jan.
To investigate the association between serum 25-hydroxyvitamin D (25[OH]D) concentration and refractive error in a community-based cohort of adults aged 46 to 69 years.
Residents of the City of Busselton in Western Australia born between 1946 and 1964 were invited to participate. Participants underwent cycloplegic autorefraction and completed questionnaires on education, occupational sun exposure, and physical activity. Blood samples were collected and serum frozen at -80°C. Serum 25[OH]D concentration was measured by immunoassay. Data on 25[OH]D were deseasonalized and multivariate models built to analyze the association between 25[OH]D concentration and spherical equivalent and myopia, defined as spherical equivalent <-0.50 D.
After exclusions, data were available for 4112 participants. Serum 25[OH]D concentration was not associated with spherical equivalent or myopia after adjustment for confounding factors (β = -0.01, 95% confidence interval [CI]: -0.03 to -0.008, = 0.25, and odds ratio = 1.02, 95% CI: 0.99 to 1.05, = 0.12, respectively). When participants were classified into 25[OH]D groups of lower (<50 nmol/L), medium (≥50 to <75 nmol/L), and upper (≥75 nmol/L), the upper group had slightly greater myopic refractive error than the medium group ( = 0.02) but not the lower group, after adjustment for confounders.
There was no substantial association between 25[OH]D levels and spherical equivalent or odds of myopia in this study. The association previously noted between low serum 25[OH]D level and myopia in younger Western Australians is not evident in later adulthood.
This study provides further evidence suggesting that vitamin D levels are unrelated to myopia risk in adults and thus not a suitable target for myopia intervention.
在一个年龄在46至69岁的社区成年人群体中,研究血清25-羟基维生素D(25[OH]D)浓度与屈光不正之间的关联。
邀请了西澳大利亚州巴瑟尔顿市1946年至1964年出生的居民参与。参与者接受了睫状肌麻痹验光,并完成了关于教育程度、职业性阳光暴露和体育活动的问卷调查。采集血样并将血清在-80°C下冷冻。通过免疫测定法测量血清25[OH]D浓度。对25[OH]D数据进行去季节性处理,并建立多变量模型来分析25[OH]D浓度与球镜当量以及近视(定义为球镜当量<-0.50 D)之间的关联。
排除相关因素后,有4112名参与者的数据可供分析。在对混杂因素进行调整后,血清25[OH]D浓度与球镜当量或近视无关联(β = -0.01,95%置信区间[CI]:-0.03至-0.008,P = 0.25;优势比 = 1.02,95% CI:0.99至1.05,P = 0.12)。当将参与者分为25[OH]D低水平组(<50 nmol/L)、中等水平组(≥50至<75 nmol/L)和高水平组(≥75 nmol/L)时,在对混杂因素进行调整后,高水平组的近视屈光不正略高于中等水平组(P = 0.02),但与低水平组无差异。
在本研究中,25[OH]D水平与球镜当量或近视几率之间无显著关联。先前在西澳大利亚州较年轻人群中发现的低血清25[OH]D水平与近视之间的关联在成年后期并不明显。
本研究提供了进一步的证据,表明维生素D水平与成年人近视风险无关,因此不是近视干预的合适靶点。